Interferon-gamma release assays
- PMID: 24856531
- DOI: 10.1016/j.cll.2014.02.007
Interferon-gamma release assays
Abstract
Diagnosis of latent tuberculosis infection (LTBI) should be targeted toward individuals and groups with high risk of progression to active tuberculosis (TB). Low-risk populations should not be screened. Interferon-gamma release assays (IGRAs) perform as well or better than the tuberculin skin test in most targeted populations. IGRAs are preferred for bacille Calmette-Guérin (BCG)-vaccinated populations. A positive IGRA in a person at low risk for TB exposure should be confirmed with a repeat test or another method before recommending LTBI treatment. The choice of which IGRA to use is generally based on the costs and feasibility of performing the test.
Keywords: Interferon-gamma release assays; Latent tuberculosis infection; QuantiFERON; T-SPOT; Tuberculin skin test; Tuberculosis.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical